Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis. (Q51010265)

27 March 2018

title

Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis. (English)

1 reference

27 March 2018

0 references

3

1 reference

27 March 2018

author name string

Thomson MA

1

1 reference

27 March 2018

Wilmott RW

2

1 reference

27 March 2018

Masters B

4

1 reference

27 March 2018

Francis PJ

5

1 reference

27 March 2018

Shepherd RW

6

1 reference

27 March 2018

language of work or name

English

0 references

publication date

1 September 1996

1 reference

27 March 2018

The Journal of Pediatrics

published in

1 reference

27 March 2018

volume

129

1 reference

27 March 2018

issue

3

1 reference

27 March 2018

page(s)

367-373

1 reference

27 March 2018

Relative underweight in cystic fibrosis and its prognostic value

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Nutritional rehabilitation in cystic fibrosis: controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Increased resting energy expenditure in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Increased energy expenditure in cystic fibrosis is associated with specific mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Measured versus predicted resting energy expenditure in infants: a need for reappraisal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Resting energy expenditure in infants with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Increased energy expenditure in young children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

The cystic fibrosis gene and resting energy expenditure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Assessment of total energy expenditure in free-living patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Resting energy expenditure before and after treatment for Pseudomonas aeruginosa infection in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Effect of salbutamol on resting energy expenditure in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Nutritional Rehabilitation Increases Resting Energy Expenditure Without Affecting Protein Turnover in Patients with Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Normal energy expenditure in the infant with presymptomatic cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

RELATIONSHIP OF ENERGY EXPENDITURE TO TOTAL EXCHANGEABLE POTASSIUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Total Body Potassium in Cystic Fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Evaluation of growth and changes in body composition following neonatal diagnosis of cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Monoclonal antibody-based enzyme immunoassay for trypsinogen in neonatal screening for cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Routine use of hair root or buccal swab specimens for PCR analysis: advantages over using blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Neonatal screening for cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Replication-deficient adenovirus induces expression of interleukin-8 by airway epithelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Electron microprobe analysis of human labial gland secretory granules in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Cystic fibrosis transmembrane conductance regulator: a chloride channel with novel regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Regulation of CFTR Cl- conductance in secretion by cellular energy levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Mitochondrial calcium uptake and oxygen consumption in cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Energy needs and growth in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

Longitudinal study of the body composition of weight gain in exclusively breast-fed and intake-measured whey-based formula-fed infants to age 3 months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2896%2970068-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(96)70068-9

1 reference

27 March 2018

1 reference

27 March 2018